07.02.2023 - TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) - Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of innovative technologies and novel therapeutics targeting .
The Kidney March, the Kidney Foundation of Canada s signature event, is back in full form for its 13th annual outing after a couple of years of doing things a little bit differently in the face of the COVID-19 pandemic.